Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
JXtzZ2uLMg0TQjdm
Listen
